Effective immunotherapy against cancer: A question of overcoming immune suppression and immune escape?

By Malmberg Karl-Johan  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 10, 2004-10 ,pp. : 879-892

Springer Publishing Company

Access to resources Recommend Favorite

Development of anti-PAX3 immune responses; a target for cancer immunotherapy

By Himoudi Nourredine   Nabarro Steven   Yan Mengyong   Gilmour Kimberly   Thrasher Adrian   Anderson John  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 9, 2007-09 ,pp. : 1381-1395

Springer Publishing Company

Access to resources Recommend Favorite

Immune Modulation by Androgen Deprivation and Radiation Therapy: Implications for Prostate Cancer Immunotherapy

By Kalina Jennifer L.   Neilson David S.   Comber Alexandra P.   Rauw Jennifer M.   Alexander Abraham S.   Vergidis Joanna   Lum Julian J.  

Cancers, Vol. 9, Iss. 2, 2017-01 ,pp. : 13-13

MDPI

Access to resources Recommend Favorite

Tumor-Infiltrating Lymphocytes Contain Higher Numbers of Type 1 Cytokine Expressors and DR+ T Cells Compared with Lymphocytes from Tumor Draining Lymph Nodes and Peripheral Blood in Patients with Cancer of the Uterine Cervix

By Santin A.D.   Ravaggi A.   Bellone S.   Pecorelli S.   Cannon M.   Parham G.P.   Hermonat P.L.  

Gynecologic Oncology, Vol. 81, Iss. 3, 2001-06 ,pp. : 424-432

Elsevier

Access to resources Recommend Favorite

HLA-I Antigen Presentation and Tapasin Influence Immune Responses Against Malignant Brain Tumors – Considerations for Successful Immunotherapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 8, 2014-10 ,pp. : 1094-1100

Bentham Science Publishers

Access to resources Recommend Favorite